Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Alex Varvares, M.D.


This page shows the publications Mark Varvares has written about Disease-Free Survival.
Connection Strength

  1. Does Clearance of Positive Margins Improve Local Control in Oral Cavity Cancer? A Meta-analysis. Otolaryngol Head Neck Surg. 2019 08; 161(2):235-244.
    View in: PubMed
    Score: 0.089
  2. Preoperative laboratory data are associated with complications and surgical site infection in composite head and neck surgical resections. Am J Otolaryngol. 2018 May - Jun; 39(3):261-265.
    View in: PubMed
    Score: 0.082
  3. Decreased cancer-independent life expectancy in the head and neck cancer population. Head Neck. 2017 09; 39(9):1845-1853.
    View in: PubMed
    Score: 0.079
  4. Oncologic Outcomes of Invasive Squamous Cell Carcinoma of the Scalp Requiring Resection of Cranial Bone. J Neurol Surg A Cent Eur Neurosurg. 2016 Jul; 77(4):308-11.
    View in: PubMed
    Score: 0.071
  5. Long-Term Outcomes After Proton Beam Therapy for Sinonasal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):368-376.
    View in: PubMed
    Score: 0.018
  6. Tumor-infiltrating ?d T lymphocytes predict clinical outcome in human breast cancer. J Immunol. 2012 Nov 15; 189(10):5029-36.
    View in: PubMed
    Score: 0.014
  7. Management outcomes following lateral temporal bone resection for ear and temporal bone malignancies. Otolaryngol Head Neck Surg. 2007 Dec; 137(6):893-8.
    View in: PubMed
    Score: 0.010
  8. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg. 2006 Nov; 132(11):1242-9.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.